EPIDERMOLYSIS BULLOSA
Clinical trials for EPIDERMOLYSIS BULLOSA explained in plain language.
Never miss a new study
Get alerted when new EPIDERMOLYSIS BULLOSA trials appear
Sign up with your email to follow new studies for EPIDERMOLYSIS BULLOSA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to speed healing for fragile skin disease
Disease control Recruiting nowThis study is testing whether adding IV IgG (intravenous immunoglobulin) to an existing gene therapy (VYJUVEK) helps wounds heal faster and better in people with recessive dystrophic epidermolysis bullosa (RDEB). It will enroll 8 participants who already have significant blisteri…
Matched conditions: EPIDERMOLYSIS BULLOSA
Phase: PHASE1, PHASE2 • Sponsor: M. Peter Marinkovich • Aim: Disease control
Last updated Apr 03, 2026 21:25 UTC
-
New gel offers hope for healing fragile skin in rare genetic condition
Disease control Recruiting nowThis study is testing whether Oleogel-S10 gel helps close wounds in people with two types of epidermolysis bullosa (EB), a rare genetic condition that causes fragile, blistering skin. Japanese children and adults with confirmed EB will apply the gel to their wounds for 45 days wh…
Matched conditions: EPIDERMOLYSIS BULLOSA
Phase: PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC